<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34376243</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>Molecular neurodegeneration</Title><ISOAbbreviation>Mol Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>52</StartPage><MedlinePgn>52</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">52</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13024-021-00470-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a multifactorial, multisystem motor neuron disease for which currently there is no effective treatment. There is an urgent need to identify biomarkers to tackle the disease's complexity and help in early diagnosis, prognosis, and therapy. Extracellular vesicles (EVs) are nanostructures released by any cell type into body fluids. Their biophysical and biochemical characteristics vary with the parent cell's physiological and pathological state and make them an attractive source of multidimensional data for patient classification and stratification.</AbstractText><AbstractText Label="METHODS">We analyzed plasma-derived EVs of ALS patients (n&#x2009;=&#x2009;106) and controls (n&#x2009;=&#x2009;96), and SOD1<sup>G93A</sup> and TDP-43<sup>Q331K</sup> mouse models of ALS. We purified plasma EVs by nickel-based isolation, characterized their EV size distribution and morphology respectively by nanotracking analysis and transmission electron microscopy, and analyzed EV markers and protein cargos by Western blot and proteomics. We used machine learning techniques to predict diagnosis and prognosis.</AbstractText><AbstractText Label="RESULTS">Our procedure resulted in high-yield isolation of intact and polydisperse plasma EVs, with minimal lipoprotein contamination. EVs in the plasma of ALS patients and the two mouse models of ALS had a distinctive size distribution and lower HSP90 levels compared to the controls. In terms of disease progression, the levels of cyclophilin A with the EV size distribution distinguished fast and slow disease progressors, a possibly new means for patient stratification. Immuno-electron microscopy also suggested that phosphorylated TDP-43 is not an intravesicular cargo of plasma-derived EVs.</AbstractText><AbstractText Label="CONCLUSIONS">Our analysis unmasked features in plasma EVs of ALS patients with potential straightforward clinical application. We conceived an innovative mathematical model based on machine learning which, by integrating EV size distribution data with protein cargoes, gave very high prediction rates for disease diagnosis and prognosis.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pasetto</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callegaro</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Mathematics "Tullio Levi-Civita", University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corbelli</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiordaliso</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrara</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunelli</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sestito</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastorelli</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianchi</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cretich</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Consiglio Nazionale delle Ricerche, Istituto di Scienze e Tecnologie Chimiche "Giulio Natta" (SCITEC-CNR), Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiari</LastName><ForeName>Marcella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Consiglio Nazionale delle Ricerche, Istituto di Scienze e Tecnologie Chimiche "Giulio Natta" (SCITEC-CNR), Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potrich</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Materials and Microsystems, Fondazione Bruno Kessler, Trento, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituto di Biofisica, Consiglio Nazionale delle Ricerche, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moglia</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>'Rita Levi Montalcini' Department of Neuroscience, Universit&#xe0; degli Studi di Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corbo</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation Sciences, Casa Cura Policlinico (CCP), Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorar&#xf9;</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, University of Padova, 35122, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunetta</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre (NEMO), Serena Onlus Foundation, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>'Rita Levi Montalcini' Department of Neuroscience, Universit&#xe0; degli Studi di Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>'Rita Levi Montalcini' Department of Neuroscience, Universit&#xe0; degli Studi di Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation, ICS Maugeri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennuto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), 35129, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quattrone</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Mathematics "Tullio Levi-Civita", University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Agostino</LastName><ForeName>Vito Giuseppe</ForeName><Initials>VG</Initials><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Basso</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. manuela.basso@unitn.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Trento, Italy. manuela.basso@unitn.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bonetto</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-0456-2054</Identifier><AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. valentina.bonetto@marionegri.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Neurodegener</MedlineTA><NlmUniqueID>101266600</NlmUniqueID><ISSNLinking>1750-1326</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="N">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046529" MajorTopicYN="N">Microscopy, Electron, Transmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Extracellular vesicles</Keyword><Keyword MajorTopicYN="N">HSP90</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">PPIA</Keyword><Keyword MajorTopicYN="N">Phosphorylated TDP-43</Keyword><Keyword MajorTopicYN="N">Plasma</Keyword></KeywordList><CoiStatement>VDA and AQ declare competing interests for the patent application of the NBI procedure (WO2019122003).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34376243</ArticleId><ArticleId IdType="pmc">PMC8353748</ArticleId><ArticleId IdType="doi">10.1186/s13024-021-00470-3</ArticleId><ArticleId IdType="pii">10.1186/s13024-021-00470-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chi&#xf2; A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S, Ilardi A, Bertuzzo D, Bersano E, Cugnasco P, Grassano M, Pisano F, Mazzini L, Calvo A, for the Piemonte and Valle d&#x2019;Aosta Register for ALS (PARALS) Secular trends of amyotrophic lateral sclerosis: the Piemonte and Valle d&#x2019;Aosta register. JAMA Neurol. 2017;74(9):1097&#x2013;1104. doi: 10.1001/jamaneurol.2017.1387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1387</ArticleId><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primer. 2017;3(1):17085. doi: 10.1038/nrdp.2017.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin RJ, Fagan AM, Holtzman DM. Multimodal techniques for diagnosis and prognosis of Alzheimer&#x2019;s disease. Nature. 2009;461(7266):916&#x2013;922. doi: 10.1038/nature08538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08538</ArticleId><ArticleId IdType="pmc">PMC2810658</ArticleId><ArticleId IdType="pubmed">19829371</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E, Gray E, Ansorge O, Talbot K, Turner MR. Towards a TDP-43-based biomarker for ALS and FTLD. Mol Neurobiol. 2018;55(10):7789&#x2013;7801. doi: 10.1007/s12035-018-0947-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-0947-6</ArticleId><ArticleId IdType="pmc">PMC6132775</ArticleId><ArticleId IdType="pubmed">29460270</ArticleId></ArticleIdList></Reference><Reference><Citation>Scial&#xf2; C, Tran TH, Salzano G, Novi G, Caponnetto C, Chi&#xf2; A, et al. TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients. Brain Commun. 2020;2:fcaa142. doi: 10.1093/braincomms/fcaa142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa142</ArticleId><ArticleId IdType="pmc">PMC7566418</ArticleId><ArticleId IdType="pubmed">33094285</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Wuu J, Andersen PM, Lombardi V, Malaspina A. Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion. Ann Neurol. 2018;84(1):130&#x2013;139. doi: 10.1002/ana.25276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25276</ArticleId><ArticleId IdType="pubmed">30014505</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Wuu J, Lombardi V, Jeromin A, Bowser R, Andersen PM, et al. Neurofilaments in pre-symptomatic ALS and the impact of genotype. Amyotroph Lateral Scler Front Degener. 2019;20(7-8):538&#x2013;48. 10.1080/21678421.2019.1646769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6768722</ArticleId><ArticleId IdType="pubmed">31432691</ArticleId></ArticleIdList></Reference><Reference><Citation>De Schaepdryver M, Goossens J, De Meyer S, Jeromin A, Masrori P, Brix B, et al. Serum neurofilament heavy chains as early marker of motor neuron degeneration. Ann Clin Transl Neurol. 2019;6(10):1971&#x2013;1979. doi: 10.1002/acn3.50890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50890</ArticleId><ArticleId IdType="pmc">PMC6801162</ArticleId><ArticleId IdType="pubmed">31518073</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870&#x2013;881. doi: 10.1136/jnnp-2018-320106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-320106</ArticleId><ArticleId IdType="pubmed">30967444</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niel G, D&#x2019;Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213&#x2013;228. doi: 10.1038/nrm.2017.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.125</ArticleId><ArticleId IdType="pubmed">29339798</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;tvall J, Hill AF, Hochberg F, Buz&#xe1;s EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913. doi: 10.3402/jev.v3.26913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v3.26913</ArticleId><ArticleId IdType="pmc">PMC4275645</ArticleId><ArticleId IdType="pubmed">25536934</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of exosome composition. Cell. 2019;177:428&#x2013;445.e18. doi: 10.1016/j.cell.2019.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.02.029</ArticleId><ArticleId IdType="pmc">PMC6664447</ArticleId><ArticleId IdType="pubmed">30951670</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M, Bonetto V. Extracellular vesicles and a novel form of communication in the brain. Front Neurosci. 2016;10:127. doi: 10.3389/fnins.2016.00127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00127</ArticleId><ArticleId IdType="pmc">PMC4814526</ArticleId><ArticleId IdType="pubmed">27065789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara D, Pasetto L, Bonetto V, Basso M. Role of extracellular vesicles in amyotrophic lateral sclerosis. Front Neurosci. 2018;12:574. doi: 10.3389/fnins.2018.00574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00574</ArticleId><ArticleId IdType="pmc">PMC6107782</ArticleId><ArticleId IdType="pubmed">30174585</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M, Pozzi S, Tortarolo M, Fiordaliso F, Bisighini C, Pasetto L, Spaltro G, Lidonnici D, Gensano F, Battaglia E, Bendotti C, Bonetto V. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem. 2013;288(22):15699&#x2013;15711. doi: 10.1074/jbc.M112.425066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.425066</ArticleId><ArticleId IdType="pmc">PMC3668729</ArticleId><ArticleId IdType="pubmed">23592792</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D, La Salvia S, Giannini M, Crippa V, Gagliardi S, Bernuzzi S, et al. Pathological proteins are transported by extracellular vesicles of sporadic amyotrophic lateral sclerosis patients. Front Neurosci. 2018;12:487. doi: 10.3389/fnins.2018.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00487</ArticleId><ArticleId IdType="pmc">PMC6060258</ArticleId><ArticleId IdType="pubmed">30072868</ArticleId></ArticleIdList></Reference><Reference><Citation>Haqqani AS, Delaney CE, Tremblay T-L, Sodja C, Sandhu JK, Stanimirovic DB. Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS. 2013;10(1):4. doi: 10.1186/2045-8118-10-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-10-4</ArticleId><ArticleId IdType="pmc">PMC3560214</ArticleId><ArticleId IdType="pubmed">23305214</ArticleId></ArticleIdList></Reference><Reference><Citation>Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018;2018:8545347. doi: 10.1155/2018/8545347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/8545347</ArticleId><ArticleId IdType="pmc">PMC5831698</ArticleId><ArticleId IdType="pubmed">29662902</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarangelo M, Zucal C, Modelska A, Pesce I, Scarduelli G, Potrich C, Lunelli L, Pederzolli C, Pavan P, la Marca G, Pasini L, Ulivi P, Beltran H, Demichelis F, Provenzani A, Quattrone A, D'Agostino VG. Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood. EBioMedicine. 2019;43:114&#x2013;126. doi: 10.1016/j.ebiom.2019.04.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.04.039</ArticleId><ArticleId IdType="pmc">PMC6558028</ArticleId><ArticleId IdType="pubmed">31047861</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino M, Papa S, Crippa V, Nardo G, Peviani M, Cheroni C, Trolese MC, Lauranzano E, Bonetto V, Poletti A, DeBiasi S, Ferraiuolo L, Shaw PJ, Bendotti C. Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36(1):492&#x2013;504. doi: 10.1016/j.neurobiolaging.2014.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.06.026</ArticleId><ArticleId IdType="pubmed">25085783</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold ES, Ling S-C, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, Kordasiewicz HB, McAlonis-Downes M, Platoshyn O, Parone PA, da Cruz S, Clutario KM, Swing D, Tessarollo L, Marsala M, Shaw CE, Yeo GW, Cleveland DW. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A. 2013;110(8):E736&#x2013;E745. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarangelo M, Ferrara D, Potrich C, Lunelli L, Vanzetti L, Provenzani A, et al. Rapid nickel-based isolation of extracellular vesicles from different biological fluids. BIO-Protoc. 2020;10:e3512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7842538</ArticleId><ArticleId IdType="pubmed">33654737</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671&#x2013;675. doi: 10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorente A, Skotland T, Sylv&#xe4;nne T, Kauhanen D, R&#xf3;g T, Or&#x142;owski A, et al. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta. 1831;2013:1302&#x2013;1309.</Citation><ArticleIdList><ArticleId IdType="pubmed">24046871</ArticleId></ArticleIdList></Reference><Reference><Citation>Haraszti RA, Didiot M-C, Sapp E, Leszyk J, Shaffer SA, Rockwell HE, Gao F, Narain NR, DiFiglia M, Kiebish MA, Aronin N, Khvorova A. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016;5(1):32570. doi: 10.3402/jev.v5.32570.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v5.32570</ArticleId><ArticleId IdType="pmc">PMC5116062</ArticleId><ArticleId IdType="pubmed">27863537</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunelli L, Llansola M, Felipo V, Campagna R, Airoldi L, De Paola M, et al. Insight into the neuroproteomics effects of the food-contaminant non-dioxin like polychlorinated biphenyls. J Proteome. 2012;75(8):2417&#x2013;2430. doi: 10.1016/j.jprot.2012.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2012.02.023</ArticleId><ArticleId IdType="pubmed">22387315</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26(12):1367&#x2013;1372. doi: 10.1038/nbt.1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1511</ArticleId><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, Mann M, Cox J. The Perseus computational platform for comprehensive analysis of (prote) omics data. Nat Methods. 2016;13(9):731&#x2013;740. doi: 10.1038/nmeth.3901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3901</ArticleId><ArticleId IdType="pubmed">27348712</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhmann M. Radial Basis Functions: Theory and Implementations (Cambridge Monographs on Applied and Computational Mathematics). Cambridge: Cambridge University Press;&#xa0;2003. 10.1017/CBO9780511543241.</Citation></Reference><Reference><Citation>De Gaetano A, Panunzi S, Rinaldi F, Risi A, Sciandrone M. A patient adaptable ECG beat classifier based on neural networks. Appl Math Comput. 2009;213(1):243&#x2013;249. doi: 10.1016/j.amc.2009.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amc.2009.03.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Barua S, Islam MM, Yao X, Murase K. MWMOTE&#x2013;majority weighted minority oversampling technique for imbalanced data set learning. IEEE Trans Knowl Data Eng. 2014;26(2):405&#x2013;425. doi: 10.1109/TKDE.2012.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TKDE.2012.232</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos MS, Soraes J, Araujo H, Santos J. Cross-validation for imbalanced datasets: avoiding overoptimistic and Overfitting approaches [research frontier] IEEE Comput Intell Mag. 2018;13(4):59&#x2013;76. doi: 10.1109/MCI.2018.2866730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/MCI.2018.2866730</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone M. Cross-Validatory choice and assessment of statistical predictions (with discussion) J R Stat Soc Ser B Methodol. 1976;38:102.</Citation></Reference><Reference><Citation>Van Deun J, Mestdagh P, Sormunen R, Cocquyt V, Vermaelen K, Vandesompele J, et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles.&#xa0;2014;3. 10.3402/jev.v3.24858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4169610</ArticleId><ArticleId IdType="pubmed">25317274</ArticleId></ArticleIdList></Reference><Reference><Citation>Witwer KW, Soekmadji C, Hill AF, Wauben MH, Buz&#xe1;s EI, Di Vizio D, et al. Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility. J Extracell Vesicles. 2017;6(1):1396823. doi: 10.1080/20013078.2017.1396823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2017.1396823</ArticleId><ArticleId IdType="pmc">PMC5698937</ArticleId><ArticleId IdType="pubmed">29184626</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner C, Di Vizio D, Sahoo S, Th&#xe9;ry C, Witwer KW, Wauben M, et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles. 2016;5(1):32945. doi: 10.3402/jev.v5.32945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v5.32945</ArticleId><ArticleId IdType="pmc">PMC5090131</ArticleId><ArticleId IdType="pubmed">27802845</ArticleId></ArticleIdList></Reference><Reference><Citation>Webber J, Clayton A. How pure are your vesicles? J Extracell Vesicles. 2013;2(1). 10.3402/jev.v2i0.19861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760653</ArticleId><ArticleId IdType="pubmed">24009896</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin JZ, Lee Y, Vader P, M&#xe4;ger I, Johansson HJ, Heusermann W, Wiklander OPB, H&#xe4;llbrink M, Seow Y, Bultema JJ, Gilthorpe J, Davies T, Fairchild PJ, Gabrielsson S, Meisner-Kober NC, Lehti&#xf6; J, Smith CIE, Wood MJA, Andaloussi SEL. Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomedicine Nanotechnol Biol Med. 2015;11(4):879&#x2013;883. doi: 10.1016/j.nano.2015.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nano.2015.01.003</ArticleId><ArticleId IdType="pubmed">25659648</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuana Y, Levels J, Grootemaat A, Sturk A, Nieuwland R. Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation. J Extracell Vesicles. 2014;3(1). 10.3402/jev.v3.23262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090368</ArticleId><ArticleId IdType="pubmed">25018865</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf3;dar BW, Kittel &#xc1;, P&#xe1;l&#xf3;czi K, Vukman KV, Osteikoetxea X, Szab&#xf3;-Taylor K, N&#xe9;meth A, Sperl&#xe1;gh B, Baranyai T, Giricz Z, Wiener Z, Turi&#xe1;k L, Drahos L, P&#xe1;llinger &#xc9;, V&#xe9;key K, Ferdinandy P, Falus A, Buz&#xe1;s EI. Low-density lipoprotein mimics blood plasma-derived exosomes and microvesicles during isolation and detection. Sci Rep. 2016;6(1):24316. doi: 10.1038/srep24316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24316</ArticleId><ArticleId IdType="pmc">PMC4834552</ArticleId><ArticleId IdType="pubmed">27087061</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen JB. What are we looking at? Extracellular vesicles, lipoproteins, or both? Circ Res. 2017;121(8):920&#x2013;922. doi: 10.1161/CIRCRESAHA.117.311767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.311767</ArticleId><ArticleId IdType="pubmed">28963190</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M, Samengo G, Nardo G, Massignan T, D&#x2019;Alessandro G, Tartari S, et al. Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis. PLoS One. 2009;4(12):e8130. doi: 10.1371/journal.pone.0008130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008130</ArticleId><ArticleId IdType="pmc">PMC2780298</ArticleId><ArticleId IdType="pubmed">19956584</ArticleId></ArticleIdList></Reference><Reference><Citation>Filareti M, Luotti S, Pasetto L, Pignataro M, Paolella K, Messina P, et al. Decreased Levels of Foldase and chaperone proteins are associated with an early-onset amyotrophic lateral sclerosis. Front Mol Neurosci. 2017;10:99. doi: 10.3389/fnmol.2017.00099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00099</ArticleId><ArticleId IdType="pmc">PMC5382314</ArticleId><ArticleId IdType="pubmed">28428745</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauranzano E, Pozzi S, Pasetto L, Stucchi R, Massignan T, Paolella K, Mombrini M, Nardo G, Lunetta C, Corbo M, Mora G, Bendotti C, Bonetto V. Peptidylprolyl isomerase a governs TARDBP function and assembly in heterogeneous nuclear ribonucleoprotein complexes. Brain. 2015;138(4):974&#x2013;991. doi: 10.1093/brain/awv005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv005</ArticleId><ArticleId IdType="pubmed">25678563</ArticleId></ArticleIdList></Reference><Reference><Citation>Luotti S, Pasetto L, Porcu L, Torri V, Elezgarai SR, Pantalone S, Filareti M, Corbo M, Lunetta C, Mora G, Bonetto V. Diagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosis. Neurobiol Dis. 2020;139:104815. doi: 10.1016/j.nbd.2020.104815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104815</ArticleId><ArticleId IdType="pubmed">32087285</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala-Mar S, Donoso-Quezada J, Gallo-Villanueva RC, Perez-Gonzalez VH, Gonz&#xe1;lez-Valdez J. Recent advances and challenges in the recovery and purification of cellular exosomes. Electrophoresis. 2019;40(23-24):3036&#x2013;3049. doi: 10.1002/elps.201800526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/elps.201800526</ArticleId><ArticleId IdType="pmc">PMC6972601</ArticleId><ArticleId IdType="pubmed">31373715</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi N, Cvjetkovic A, Jang SC, Crescitelli R, Hosseinpour Feizi MA, Nieuwland R, L&#xf6;tvall J, L&#xe4;sser C. Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins. Cell Mol Life Sci CMLS. 2018;75(15):2873&#x2013;2886. doi: 10.1007/s00018-018-2773-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2773-4</ArticleId><ArticleId IdType="pmc">PMC6021463</ArticleId><ArticleId IdType="pubmed">29441425</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis L, Sadovsky Y. The biology of extracellular vesicles: the known unknowns. PLoS Biol. 2019;17(7):e3000363. doi: 10.1371/journal.pbio.3000363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000363</ArticleId><ArticleId IdType="pmc">PMC6667152</ArticleId><ArticleId IdType="pubmed">31318874</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Yan J, Shen X, Sun Y, Thulin M, Cai Y, Wik L, Shen Q, Oelrich J, Qian X, Dubois KL, Ronquist KG, Nilsson M, Landegren U, Kamali-Moghaddam M. Profiling surface proteins on individual exosomes using a proximity barcoding assay. Nat Commun. 2019;10(1):3854. doi: 10.1038/s41467-019-11486-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11486-1</ArticleId><ArticleId IdType="pmc">PMC6710248</ArticleId><ArticleId IdType="pubmed">31451692</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology. 2015;85(1):40&#x2013;47. doi: 10.1212/WNL.0000000000001702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001702</ArticleId><ArticleId IdType="pmc">PMC4501943</ArticleId><ArticleId IdType="pubmed">26062630</ArticleId></ArticleIdList></Reference><Reference><Citation>Rome S, Forterre A, Mizgier ML, Bouzakri K. Skeletal muscle-released extracellular vesicles: state of the art. Front Physiol. 2019;10:929. doi: 10.3389/fphys.2019.00929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00929</ArticleId><ArticleId IdType="pmc">PMC6695556</ArticleId><ArticleId IdType="pubmed">31447684</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, K&#xfc;gler S, Ikezu T. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18(11):1584&#x2013;1593. doi: 10.1038/nn.4132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4132</ArticleId><ArticleId IdType="pmc">PMC4694577</ArticleId><ArticleId IdType="pubmed">26436904</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in Cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30(6):836&#x2013;848. doi: 10.1016/j.ccell.2016.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2016.10.009</ArticleId><ArticleId IdType="pmc">PMC5157696</ArticleId><ArticleId IdType="pubmed">27960084</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM, Li D, Thal DR, Walther P, Ludolph AC, Danzer KM, Weishaupt JH. TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol. 2015;211(4):897&#x2013;911. doi: 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y, et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain J Neurol. 2016;2016(139):3187&#x2013;3201. doi: 10.1093/brain/aww237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww237</ArticleId><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M, Chen J, Kuang L, Arenas A, Zhai J, Zhu H, et al. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochim Biophys Acta. 1862;2016:2004&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5055831</ArticleId><ArticleId IdType="pubmed">27460707</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, Jensen BK, Wen X, Cai J, Kropf E, Iacovitti L, Pasinelli P, Trotti D. Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS/FTD. Cell Rep. 2016;17(3):645&#x2013;652. doi: 10.1016/j.celrep.2016.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.032</ArticleId><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferri&#xe8;re F, Maniecka Z, P&#xe9;rez-Berlanga M, Hruska-Plochan M, Gilhespy L, Hock E-M, Wagner U, Afroz T, Boersema PJ, Barmettler G, Foti SC, Asi YT, Isaacs AM, al-Amoudi A, Lewis A, Stahlberg H, Ravits J, de Giorgi F, Ichas F, Bezard E, Picotti P, Lashley T, Polymenidou M. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat Neurosci. 2019;22(1):65&#x2013;77. doi: 10.1038/s41593-018-0294-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0294-y</ArticleId><ArticleId IdType="pubmed">30559480</ArticleId></ArticleIdList></Reference><Reference><Citation>Palviainen M, Saraswat M, Varga Z, Kitka D, Neuvonen M, Puhka M, Joenv&#xe4;&#xe4;r&#xe4; S, Renkonen R, Nieuwland R, Takatalo M, Siljander PRM. Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo-implications for biomarker discovery. PLoS One. 2020;15(8):e0236439. doi: 10.1371/journal.pone.0236439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236439</ArticleId><ArticleId IdType="pmc">PMC7446890</ArticleId><ArticleId IdType="pubmed">32813744</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008;105(38):14265&#x2013;14270. doi: 10.1073/pnas.0805135105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0805135105</ArticleId><ArticleId IdType="pmc">PMC2567179</ArticleId><ArticleId IdType="pubmed">18809927</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E, Steinacker P, Lehnert S, Schneider A, Walther P, Thal DR, Linsenmeier M, Ludolph AC, Otto M. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph Lateral Scler Front Degener. 2014;15(5-6):351&#x2013;356. doi: 10.3109/21678421.2014.905606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.905606</ArticleId><ArticleId IdType="pubmed">24834468</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor&#xe1;n Luengo T, Mayer MP, R&#xfc;diger SGD. The Hsp70-Hsp90 chaperone Cascade in protein folding. Trends Cell Biol. 2019;29(2):164&#x2013;177. doi: 10.1016/j.tcb.2018.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.10.004</ArticleId><ArticleId IdType="pubmed">30502916</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi V, Bombaci A, Zampedri L, Lu C-H, Malik B, Zetterberg H, Heslegrave AJ, Rinaldi C, Greensmith L, Hanna MG, Malaspina A, Fratta P. Plasma pNfH levels differentiate SBMA from ALS. J Neurol Neurosurg Psychiatry. 2020;91(2):215&#x2013;217. doi: 10.1136/jnnp-2019-320624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320624</ArticleId><ArticleId IdType="pubmed">31575607</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH, Petzold A, Topping J, Allen K, Macdonald-Wallis C, Clarke J, Pearce N, Kuhle J, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Greensmith L, Malaspina A. Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study. J Neurol Neurosurg Psychiatry. 2015;86(5):565&#x2013;573. doi: 10.1136/jnnp-2014-307672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-307672</ArticleId><ArticleId IdType="pmc">PMC4413806</ArticleId><ArticleId IdType="pubmed">25009280</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F, Steinacker P, Weishaupt JH, Kassubek J, Oeckl P, Halbgebauer S, Tumani H, von Arnim CAF, Dorst J, Feneberg E, Mayer B, M&#xfc;ller HP, Gorges M, Rosenbohm A, Volk AE, Silani V, Ludolph AC, Otto M. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(2):157&#x2013;164. doi: 10.1136/jnnp-2018-318704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318704</ArticleId><ArticleId IdType="pubmed">30309882</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Zhang L, Wang L, Granit V, Statland J, Barohn R, Swenson A, Ravits J, Jackson C, Burns TM, Trivedi J, Pioro EP, Caress J, Katz J, McCauley J, Rademakers R, Malaspina A, Ostrow LW, Wuu J, CReATe Consortium Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology. 2020;95(1):e59&#x2013;e69. doi: 10.1212/WNL.0000000000009559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009559</ArticleId><ArticleId IdType="pmc">PMC7371380</ArticleId><ArticleId IdType="pubmed">32385188</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V, Pradat P-F, Querin G, Delbot F, Le Chat G, Pradat-Peyre J-F, et al. Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions. Front Neurosci. 2019;13:135. doi: 10.3389/fnins.2019.00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00135</ArticleId><ArticleId IdType="pmc">PMC6403867</ArticleId><ArticleId IdType="pubmed">30872992</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AA, Fournier C, Polak M, Wang L, Zach N, Keymer M, Glass JD, Ennist DL, The Pooled Resource Open&#x2010;Access ALS Clinical Trials Consortium Predicting disease progression in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2016;3(11):866&#x2013;875. doi: 10.1002/acn3.348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.348</ArticleId><ArticleId IdType="pmc">PMC5099532</ArticleId><ArticleId IdType="pubmed">27844032</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Zhang H, Boss J, Goutman SA, Mukherjee B, Dinov ID, Guan Y, for the Pooled Resource Open-Access ALS Clinical Trials Consortium Complete hazard ranking to analyze right-censored data: an ALS survival study. PLoS Comput Biol. 2017;13(12):e1005887. doi: 10.1371/journal.pcbi.1005887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1005887</ArticleId><ArticleId IdType="pmc">PMC5749893</ArticleId><ArticleId IdType="pubmed">29253881</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfohl SR, Kim RB, Coan GS, Mitchell CS. Unraveling the complexity of amyotrophic lateral sclerosis survival prediction. Front Neuroinformatics. 2018;12:36. doi: 10.3389/fninf.2018.00036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fninf.2018.00036</ArticleId><ArticleId IdType="pmc">PMC6010549</ArticleId><ArticleId IdType="pubmed">29962944</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibold H, Zeileis A, Hothorn T. Individual treatment effect prediction for amyotrophic lateral sclerosis patients. Stat Methods Med Res. 2018;27(10):3104&#x2013;3125. doi: 10.1177/0962280217693034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280217693034</ArticleId><ArticleId IdType="pubmed">29298618</ArticleId></ArticleIdList></Reference><Reference><Citation>von Neuhoff N, Oumeraci T, Wolf T, Kollewe K, Bewerunge P, Neumann B, Brors B, Bufler J, Wurster U, Schlegelberger B, Dengler R, Zapatka M, Petri S. Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic. PLoS One. 2012;7(9):e44401. doi: 10.1371/journal.pone.0044401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044401</ArticleId><ArticleId IdType="pmc">PMC3435306</ArticleId><ArticleId IdType="pubmed">22970211</ArticleId></ArticleIdList></Reference><Reference><Citation>Bereman MS, Beri J, Enders JR, Nash T. Machine learning reveals protein signatures in CSF and plasma fluids of clinical value for ALS. Sci Rep. 2018;8(1):16334. doi: 10.1038/s41598-018-34642-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34642-x</ArticleId><ArticleId IdType="pmc">PMC6218542</ArticleId><ArticleId IdType="pubmed">30397248</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C, Bonetto V, Pupillo E, Logroscino G, Al-Chalabi A, Lunetta C, et al. Focus on the heterogeneity of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener.&#xa0;2020;21(7-8):485-95. 10.1080/21678421.2020.1779298.</Citation><ArticleIdList><ArticleId IdType="pubmed">32583689</ArticleId></ArticleIdList></Reference><Reference><Citation>Myszczynska MA, Ojamies PN, Lacoste AMB, Neil D, Saffari A, Mead R, Hautbergue GM, Holbrook JD, Ferraiuolo L. Applications of machine learning to diagnosis and treatment of neurodegenerative diseases. Nat Rev Neurol. 2020;16(8):440&#x2013;456. doi: 10.1038/s41582-020-0377-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0377-8</ArticleId><ArticleId IdType="pubmed">32669685</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>